We examined two medications commonly prescribed for gout, benzbromarone that suppress uric acid reabsorption at renal tubules and colchicine that disrupts microtubule assembly38, to see if they affected ALPK1, myosin IIA, and TNF-α levels. The gene discussed is ALPK1; the disease is gout.